Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

Becerra Dodges Written Questions About Plans For Drug Pricing Rules

By John Wilkerson / March 4, 2021 at 4:27 PM
Lobbyists looking for clues on how the Biden administration will handle the Trump administration’s last-minute efforts to ban drug rebates and tie Medicare reimbursement to foreign drug prices didn’t get much help from HHS Secretary-nominee Xavier Becerra’s responses to Senate Finance Committee members’ written questions. The Trump administration finished both rules shortly before leaving office, and the Biden administration froze them for review. The courts also delayed both regulations. Following a court order , HHS delayed for one year its...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.